Phase 3 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older at the time of screening
- You are willing and able to follow all study procedures, including completing a study diary at least 70% of the time over a 2-week period
- You have been diagnosed with carcinoid syndrome that needs medical treatment, and you experience flushing episodes (with or without frequent bowel movements) — specifically, more than 1 flushing episode per day on average over 14 days (either without current treatment, or during a washout period if coming off existing treatment)
- You have confirmed advanced or metastatic well-differentiated neuroendocrine tumors (a type of slow-growing cancer) supported by documented test results
- Your disease has not significantly worsened in the 6 months before joining the trial, as assessed by the study doctor
Who may not be able to join:
- Your diarrhea is caused by something other than carcinoid syndrome
- You have severe, uncontrolled diarrhea that has led to serious dehydration or low blood pressure
- In your doctor's opinion, you need additional or second-line treatments to manage your carcinoid syndrome symptoms
- You have received certain specific cancer treatments (such as everolimus or sunitinib) within 4 weeks before screening, or liver embolization, radiation therapy, targeted radiation (PRRT), or tumor removal surgery within 12 weeks before screening
- You have had major surgery within 8 weeks before screening
- You have had another type of cancer within the last 3 years (with some exceptions for certain treated skin cancers, fully removed breast cancer, cervical pre-cancer, or other cancers fully treated at least 3 years ago with no current signs of disease — confirm with trial site)
- You have been using insulin to treat diabetes for less than 6 weeks before joining the study
- You have poorly controlled diabetes, shown by a blood sugar control test result (HbA1c) of 8.5% or higher
- You are unable to use short-acting octreotide injections, or you have previously tried somatostatin-type medications and they did not work for you
- You have other significant health conditions not related to your primary diagnosis, such as serious heart disease, poor kidney function, or abnormal liver test results (confirm with trial site)
- You currently use or abuse alcohol or drugs
- You have been diagnosed with gallstones that are causing symptoms
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 833-276-4636
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Participants will record the number of flushing per day in a daily diary to assess the efficacy of paltusotine vs placebo in reducing flushing episodes.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.